To determine the mechanism by which GPR48/LGR4 promotes thyroid tumorigenesis, we monitored the ERK1/2 and β-catenin pathways in GPR48/LGR4-knockdown thyroid cancer cells. The gene discussed is MAPK3; the disease is thyroid gland disorder.